ArticleJournal of ovarian research2025

Atractylenolide III mitigates polycystic ovary syndrome by activating FDX1-mediated proliferation of ovarian granulocyte cells via PI3K/AKT/mTOR.

Nan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.